{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:21:29Z","timestamp":1773962489432,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,9]],"date-time":"2027-01-09T00:00:00Z","timestamp":1799452800000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK111430"],"award-info":[{"award-number":["R01DK111430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA259581"],"award-info":[{"award-number":["R01CA259581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.exphem.2025.105351","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:59:59Z","timestamp":1765814399000},"page":"105351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Splenic erythroblasts fuel leukemia progression through metabolic crosstalk"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-1716","authenticated-orcid":false,"given":"Jin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-7337","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105351_bib0001","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/2643-3230.BCD-24-0009","article-title":"A view of myeloid transformation through the hallmarks of cancer","volume":"5","author":"Fern\u00e1ndez-Maestre","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.exphem.2025.105351_bib0002","doi-asserted-by":"crossref","first-page":"eaax5104","DOI":"10.1126\/scitranslmed.aax5104","article-title":"IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2025.105351_bib0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.105351_bib0004","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1200\/JCO.2005.06.090","article-title":"Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study","volume":"23","author":"Farag","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2025.105351_bib0005","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00277-023-05353-9","article-title":"Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)","volume":"102","author":"Pohlmann","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2025.105351_bib0006","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00277-018-3278-9","article-title":"Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"97","author":"Shimomura","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2025.105351_bib0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.105351_bib0008","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193082","article-title":"Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism","volume":"135","author":"Li","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.105351_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3280de2bf1","article-title":"Molecular insights into stress erythropoiesis","volume":"14","author":"Socolovsky","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2025.105351_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exphem.2020.07.011","article-title":"Stress erythropoiesis: definitions and models for its study","volume":"89","author":"Paulson","year":"2020","journal-title":"Exp Hematol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:23:30Z","timestamp":1773951810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25006307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"alternative-id":["S0301472X25006307"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105351","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenic erythroblasts fuel leukemia progression through metabolic crosstalk","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105351"}}